Intuitive Surgical: International Expansion & Regulatory Milestones

Intuitive Surgical, Inc. reported robust third-quarter financial results for 2024, reflecting both significant positive developments and some areas of challenge. The company demonstrated strong global growth in its key product lines, particularly the da Vinci systems, which is central to its operation. On the positive side, Intuitive displayed robust procedure growth at 18% year-over-year, with contributions especially strong in the U.S., Japan, Germany, France, and the U.K. Notably, the introduction of the da Vinci 5 system, which launched in March 2024, saw promising early adoption with 188 installations and over 12,000 procedures completed. The demand signifies positive reception among healthcare institutions given the system’s advancements, such as improved force feedback technology aimed at enhancing patient outcomes.